R1	Has_qualifier Arg1:T1 Arg2:T2	
R2	AND Arg1:T5 Arg2:T4	
*	OR T5 T9 T10 T8 T6
R3	Subsumes Arg1:T2 Arg2:T5	
R4	Has_temporal Arg1:T1 Arg2:T3	
R5	Has_temporal Arg1:T18 Arg2:T17	
R6	AND Arg1:T19 Arg2:T20	
R7	Has_temporal Arg1:T19 Arg2:T21	
R8	Has_temporal Arg1:T14 Arg2:T15	
*	OR T14 T16 T18 T19
R9	Has_temporal Arg1:T13 Arg2:T12	
R10	Has_qualifier Arg1:T22 Arg2:T26	
R11	Has_qualifier Arg1:T22 Arg2:T24	
R12	Has_temporal Arg1:T22 Arg2:T27	
*	OR T28 T29 T30
R13	Subsumes Arg1:T22 Arg2:T28	
*	OR T35 T36 T39 T38 T34 T32 T33 T37
*	OR T40 T41
R14	AND Arg1:T35 Arg2:T40	
R15	Has_negation Arg1:T44 Arg2:T45	
R16	Has_qualifier Arg1:T35 Arg2:T44	
R17	Has_index Arg1:T46 Arg2:T47	
R18	Has_temporal Arg1:T35 Arg2:T46	
R19	Has_context Arg1:T35 Arg2:T48	
R20	AND Arg1:T48 Arg2:T53	
R21	Has_index Arg1:T55 Arg2:T56	
R22	Has_temporal Arg1:T54 Arg2:T55	
*	OR T57 T61
R23	Has_qualifier Arg1:T57 Arg2:T58	
R24	AND Arg1:T63 Arg2:T65	
R25	Has_index Arg1:T66 Arg2:T67	
R26	Has_temporal Arg1:T65 Arg2:T66	
R27	Has_negation Arg1:T63 Arg2:T69	
R28	Has_value Arg1:T71 Arg2:T72	
R29	Has_index Arg1:T74 Arg2:T75	
R30	AND Arg1:T68 Arg2:T71	
R31	Has_temporal Arg1:T71 Arg2:T73	
R32	Has_temporal Arg1:T71 Arg2:T74	
R33	Has_negation Arg1:T68 Arg2:T76	
*	OR T80 T81
R34	Has_qualifier Arg1:T80 Arg2:T77	
R35	Has_index Arg1:T88 Arg2:T89	
R36	AND Arg1:T86 Arg2:T87	
R37	Has_index Arg1:T93 Arg2:T94	
R38	Has_temporal Arg1:T92 Arg2:T93	
*	OR T96 T98 T97
*	OR T100 T101
R39	Subsumes Arg1:T102 Arg2:T100	
R40	AND Arg1:T100 Arg2:T96	
R41	Subsumes Arg1:T95 Arg2:T102	
*	OR T107 T108
R42	Subsumes Arg1:T106 Arg2:T107	
R43	AND Arg1:T105 Arg2:T106	
R44	Has_qualifier Arg1:T111 Arg2:T112	
R45	Subsumes Arg1:T110 Arg2:T111	
R46	Has_index Arg1:T117 Arg2:T118	
R47	Has_temporal Arg1:T116 Arg2:T117	
R48	Has_multiplier Arg1:T116 Arg2:T115	
R49	Subsumes Arg1:T2 Arg2:T7	
T1	Condition 30 36	asthma
T2	Qualifier 13 29	life-threatening
T3	Temporal 2 9	history
T4	Procedure 98 108	intubation
T5	Condition 69 83	asthma episode
T6	Condition 110 121	hypercapnea
T7	Device 132 164	non-invasive ventilatory support
T8	Condition 166 184	respiratory arrest
T9	Condition 186 202	hypoxic seizures
T10	Condition 206 237	asthma-related syncopal episode
T12	Temporal 259 266	history
T13	Condition 270 289	asthma exacerbation
T14	Drug 311 335	systemic corticosteroids
T15	Temporal 372 391	for at least 3 days
T16	Drug 397 427	depot corticosteroid injection
T17	Temporal 458 473	within 3 months
T18	Procedure 431 456	emergency room attendance
T19	Procedure 488 503	hospitalization
T20	Condition 508 514	asthma
T21	Temporal 516 531	within 6 months
T22	Condition 589 606	pulmonary disease
T23	Undefined_semantics 589 606	pulmonary disease
T24	Qualifier 554 565	Significant
T25	Subjective_judgement 554 565	Significant
T26	Qualifier 567 581	non-reversible
T27	Temporal 582 588	active
T28	Condition 613 628	cystic fibrosis
T29	Condition 630 644	bronchiectasis
T30	Condition 646 658	tuberculosis
T32	Condition 707 735;745 762	viral infection of the upper respiratory tract
T33	Condition 694 703;713 735;745 762	bacterial infection of the upper respiratory tract
T34	Condition 707 729;739 762	viral infection of the lower respiratory tract
T35	Condition 694 703;713 729;739 762	bacterial infection of the lower respiratory tract
T36	Condition 707 729;764 769	viral infection of the sinus
T37	Condition 694 703;713 729;764 769	bacterial infection of the sinus
T38	Condition 707 729;773 783	viral infection of the middle ear
T39	Condition 694 703;713 729;773 783	bacterial infection of the middle ear
T40	Procedure 662 669	Culture
T41	Observation 684 693	suspected
T44	Qualifier 796 804	resolved
T45	Negation 792 795	not
T46	Temporal 805 830	within 4 weeks of Visit 1
T47	Reference_point 823 830	Visit 1
T48	Observation 844 871	change in asthma management
T49	Subjective_judgement 876 910	in the opinion of the Investigator
T50	Non-query-able 912 933	is expected to affect
T51	Subjective_judgement 969 1014	subject's ability to participate in the study
T52	Non-query-able 969 1014	subject's ability to participate in the study
T53	Procedure 854 871	asthma management
T54	Condition 1021 1040	fracture in the leg
T55	Temporal 1056 1100	within 6 months prior to the screening visit
T56	Reference_point 1081 1100	the screening visit
T57	Condition 1107 1126	metabolic disorders
T58	Qualifier 1150 1186	may impact on normal growth patterns
T59	Subjective_judgement 1150 1186	may impact on normal growth patterns
T60	Undefined_semantics 1150 1186	may impact on normal growth patterns
T61	Condition 1130 1144	other diseases
T63	Condition 1192 1205	major surgery
T64	Undefined_semantics 1192 1205	major surgery
T65	Procedure 1216 1235	general anaesthesia
T66	Temporal 1236 1286	for at least 3 months prior to the screening visit
T67	Reference_point 1267 1286	the screening visit
T68	Condition 1292 1309	febrile illnesses
T69	Negation 1189 1191	No
T70	Grammar_Error 1189 1191	No
T71	Measurement 1315 1326	temperature
T72	Value 1327 1345	>39 degree celsius
T73	Temporal 1346 1381	for more than five consecutive days
T74	Temporal 1382 1427	within the week preceding the Screening Visit
T75	Reference_point 1408 1427	the Screening Visit
T76	Negation 1289 1291	No
T77	Qualifier 1434 1445	significant
T78	Subjective_judgement 1434 1445	significant
T79	Undefined_semantics 1434 1445	significant
T80	Condition 1446 1457	abnormality
T81	Condition 1461 1478	medical condition
T83	Subjective_judgement 1430 1714	Any significant abnormality or medical condition identified at the screening medical assessment (including serious psychological disorder) that in the Investigator's opinion, preclude entry into the study due to risk to the subject or that may interfere with the outcome of the study.
T84	Post-eligibility 1430 1714	Any significant abnormality or medical condition identified at the screening medical assessment (including serious psychological disorder) that in the Investigator's opinion, preclude entry into the study due to risk to the subject or that may interfere with the outcome of the study.
T85	Context_Error 1430 1714	Any significant abnormality or medical condition identified at the screening medical assessment (including serious psychological disorder) that in the Investigator's opinion, preclude entry into the study due to risk to the subject or that may interfere with the outcome of the study.
T86	Condition 1725 1740	visual evidence
T87	Condition 1744 1755	candidiasis
T88	Temporal 1756 1778	at Visit 1 (Screening)
T89	Reference_point 1759 1778	Visit 1 (Screening)
T90	Context_Error 1781 1841	Use of any of the prohibited medications listed in protocol.
T91	Drug 1799 1840	prohibited medications listed in protocol
T92	Condition 1843 1870	Strenuous physical exercise
T93	Temporal 1871 1908	within 3 hours of Visit 1 (Screening)
T94	Reference_point 1889 1908	Visit 1 (Screening)
T95	Condition 1910 1924	Drug allergies
T96	Drug 2002 2012;2035 2049	intranasal corticosteroid
T97	Drug 2026 2049	systemic corticosteroid
T98	Drug 2014 2021;2035 2049	inhaled corticosteroid
T100	Condition 1957 1966;1978 1994	immediate hypersensitivity
T101	Condition 1970 1994	delayed hypersensitivity
T102	Condition 1930 1946	adverse reaction
T105	Condition 2078 2089	sensitivity
T106	Drug 2097 2132	constituents of the ELLIPTA Inhaler
T107	Drug 2140 2147	lactose
T108	Drug 2149 2151	FF
T110	Condition 2155 2175	Milk Protein Allergy
T111	Condition 2195 2215	milk protein allergy
T112	Qualifier 2188 2194	severe
T113	Non-query-able 2218 2518	The subject has participated in a clinical trial and has received an investigational product within the following time period prior to the first dosing day in the current study: 30 days, 5 half-lives or twice the duration of the biological effect of the investigational product (whichever is longer).
T114	Post-eligibility 2218 2518	The subject has participated in a clinical trial and has received an investigational product within the following time period prior to the first dosing day in the current study: 30 days, 5 half-lives or twice the duration of the biological effect of the investigational product (whichever is longer).
T115	Multiplier 2532 2543	more than 4
T116	Drug 2544 2578	investigational medicinal products
T117	Temporal 2579 2625	within 12 months prior to the first dosing day
T118	Reference_point 2605 2625	the first dosing day
T119	Drug 2646 2661	ELLIPTA inhaler
T120	Device 2666 2681	peak flow meter
T121	Condition 2628 2692	Unable to use the ELLIPTA inhaler and peak flow meter correctly.
T122	Non-query-able 2628 2692	Unable to use the ELLIPTA inhaler and peak flow meter correctly.
T123	Subjective_judgement 2628 2692	Unable to use the ELLIPTA inhaler and peak flow meter correctly.
T124	Non-query-able 2694 2915	An affiliation with the Investigator site: the parents/guardians or child is an immediate family member of the participating Investigator, sub-Investigator, study coordinator, or employee of the participating Investigator
T125	Non-query-able 2918 3370	The Parent or Guardian has a history of psychiatric disease, intellectual deficiency, substance abuse or other condition (e.g. inability to read, comprehend or write) which may affect: validity of consent to participate in the study; adequate supervision of the subject during the study; compliance of subject with study medication and study procedures (e.g. completion of daily diary, attending scheduled clinic visits); subject safety and well-being.
T126	Post-eligibility 2918 3370	The Parent or Guardian has a history of psychiatric disease, intellectual deficiency, substance abuse or other condition (e.g. inability to read, comprehend or write) which may affect: validity of consent to participate in the study; adequate supervision of the subject during the study; compliance of subject with study medication and study procedures (e.g. completion of daily diary, attending scheduled clinic visits); subject safety and well-being.
T127	Context_Error 3372 3488	Children in care: Children who are wards of the government or state are not eligible for participation in this study
T128	Non-query-able 3372 3488	Children in care: Children who are wards of the government or state are not eligible for participation in this study
